The DOI matches its Crossref record.
MicroRNA-1258 Suppresses Breast Cancer Brain Metastasis by Targeting Heparanase
Open accessPublished version of a preprint
Abstract
Heparanase (HPSE) is a potent protumorigenic, proangiogenic, and prometastatic enzyme that is overexpressed in brain metastatic breast cancer (BMBC). However, little is known about the regulation of this potential therapeutic target in BMBC, which remains very poorly managed in the clinic. We hypothesized that HPSE gene expression might be regulated by micro RNA that might be exploited therapeutically. Using miRanda and RNAhybrid, we identified miR-1258 as a candidate micro RNA that may directly target HPSE and suppress BMBC. In support of our hypothesis, we found that miR-1258 levels inversely correlated with heparanase expression, enzymatic activity, and cancer cell metastatic propensities, being lowest in highly aggressive BMBC cell variants compared with either nontumorigenic or nonmetastatic human mammary epithelial cells. These findings were validated by analyses of miR-1258 and heparanase content in paired clinical specimens of normal mammary gland versus invasive ductal carcinoma, and primary breast cancer versus BMBC. In regulatory experiments, miR-1258 inhibited the expression and activity of heparanase in BMBC cells, whereas modulating heparanase blocked the phenotypic effects of miR-1258. In functional experiments, stable expression of miR-1258 in BMBC cells inhibited heparanase in vitro cell invasion and experimental brain metastasis. Together, our findings illustrate how micro RNA mechanisms are linked to brain metastatic breast cancer through heparanase control, and they offer a strong rationale to develop heparanase-based therapeutics for treatment of cancer patients with brain metastases, BMBC in particular. Cancer Res; 71(3); 645–54. ©2011 AACR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 20
- Palmieri, 2007, The biology of metastasis to a sanctuary site, Clin Cancer Res, 13, 1656, 10.1158/1078-0432.CCR-06-2659 · DOI
- Ilan, 2006, Regulation, function, and clinical significance of heparanase in cancer metastasis and angiogenesis, Int J Biochem Cell Biol, 38, 2018, 10.1016/j.biocel.2006.06.004 · DOI · Paper page
- Zcharia, 2008, Newly generated heparanase knockout mice unravel co-regulation of heparanase and matrix metalloproteinases, PLoS ONE, 4
- Zhang, 2010, EGF – induced heparanase nucleolar localization augments DNA Topoisomerase I activity in brain metastatic breast cancer, Molecular Cancer Res, 8, 278, 10.1158/1541-7786.MCR-09-0375 · DOI
- Marchetti, 2000, Astrocytes contribute to the brain-metastatic specificity of melanoma cell by producing heparanase, Cancer Res, 60, 4767
- Murry, 2006, Heparanase mechanisms of melanoma metastatic to the brain: Development and use of a brain slice model, J Cell Biochem, 97, 217, 10.1002/jcb.20714 · DOI
- Marchetti, 2001, Human heparanase: A molecular determinant of brain metastasis, Adv Enzyme Reg, 41, 343, 10.1016/S0065-2571(00)00016-9 · DOI
- Chen, 2005, MicroRNAs as oncogenes and tumor suppressors, New Engl J Med, 353, 1768, 10.1056/NEJMp058190 · DOI · Paper page
- Tavazoie, 2008, Endogenous human microRNAs that suppress breast cancer metastasis, Nature, 451, 147, 10.1038/nature06487 · DOI · Paper page
- Valastyan, 2009, A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis, Cell, 137, 1032, 10.1016/j.cell.2009.03.047 · DOI · Paper page
- Sachdeva, 2010, MicroRNA-145 suppresses cell invasion and metastasis by directly targeting mucin1, Cancer Res, 70, 378, 10.1158/0008-5472.CAN-09-2021 · DOI · Paper page
- Creighton, 2010, Molecular profiling uncovers a p53-associated role for microRNA-31 in inhibiting the proliferation of serous ovarian carcinomas and other cancers, Cancer Res, 70, 1906, 10.1158/0008-5472.CAN-09-3875 · DOI · Paper page
- Kim, 2004, Vascular endothelial growth factor expression promotes the growth of breast cancer brain metastasis in nude mice, Clin Exp Met, 21, 107, 10.1023/B:CLIN.0000024761.00373.55 · DOI · Paper page
- Rehmsmeier, 2004, Fast and effective prediction of microRNA/target duplexes, RNA, 10, 1507, 10.1261/rna.5248604 · DOI · Paper page
- Kloosterman, 2006, In situ detection of miRNA in animal embryos using LNA-modified oligonucleotide probes, Nat Methods, 3, 27, 10.1038/nmeth843 · DOI · Paper page
- Carson, 2005, A method for automated detection of gene expression required for the establishment of a digital transcriptome-wide gene expression atlas, J Microsc, 217, 275, 10.1111/j.1365-2818.2005.01450.x · DOI
- Imada, 2006, COX-2 induction by heparanase in the progression of breast cancer, Int J Mol Med, 17, 221
- Cohen-Kaplan, 2008, Heparanase auguments epidermal growth factor receptor phosphorylation: Correlation with head and neck tumor progression, Cancer Res, 68, 10077, 10.1158/0008-5472.CAN-08-2910 · DOI
- Cohen, 2006, Heparanase prompts growth, angiogenesis, and survival of primary breast tumors, Int J Cancer, 118, 1609, 10.1002/ijc.21552 · DOI
- Edovitsky, 2004, Heparanase gene silencing, tumor invasiveness, angiogenesis, and metastasis, J. Natl Cancer Inst, 96, 1219, 10.1093/jnci/djh230 · DOI · Paper page
Cited by
The biology of brain metastases—translation to new therapies
Eichler, A. F., Chung, E., Kodack, D. P., Loeffler, J. S., Fukumura, D., & Jain, R. K. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2011.58 · Cited by 567
The Identification and Characterization of Breast Cancer CTCs Competent for Brain Metastasis
Zhang, L., Ridgway, L. D., Wetzel, M. D., Ngo, J., Yin, W., Kumar, D., Goodman, J. C., Groves, M. D., & Marchetti, D. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005109 · Cited by 521
Self-citationThe extracellular matrix in breast cancer
Insua-Rodríguez, J., & Oskarsson, T. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.12.017 · Cited by 470
Metastasis Organotropism: Redefining the Congenial Soil
Gao, Y., Bado, I., Wang, H., Zhang, W., Rosen, J. M., & Zhang, X. H.-F. (2019) · Developmental Cell · doi:10.1016/j.devcel.2019.04.012 · Cited by 380
Brain metastases as preventive and therapeutic targets
Steeg, P. S., Camphausen, K. A., & Smith, Q. R. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3053 · Cited by 363
Metadata
- Authors
- Zhang, L., Sullivan, P. S., Goodman, J. C., Gunaratne, P. H., & Marchetti, D.
- Venue
- Cancer Research
- Published
- 2011-02-01
- Volume
- 71
- Issue
- 3
- Pages
- 645-654
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- OpenAlex
- W2018110352
- Cited by
- 180
- References
- 0
- FWCI
- 5.00
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: MicroRNA-1258 Suppresses Breast Cancer Brain Metastasis by Targeting Heparanase. https://app.cochat.ai/papers/10.1158/0008-5472.can-10-1910
- The paper
- Zhang, L., Sullivan, P. S., Goodman, J. C., Gunaratne, P. H., & Marchetti, D. (2011). MicroRNA-1258 Suppresses Breast Cancer Brain Metastasis by Targeting Heparanase. Cancer Research. https://doi.org/10.1158/0008-5472.can-10-1910
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.